1,373
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Intrahepatic cholestasis of pregnancy and theory of inheritance of the disease. Literature review

, ORCID Icon, , &
Article: 2279020 | Received 26 Jul 2023, Accepted 30 Oct 2023, Published online: 09 Nov 2023

References

  • Clinical updates in women’s health care summary: liver disease: reproductive considerations. Obstet Gynecol. 2017;129(1):236. doi:10.1097/AOG.0000000000001858.
  • Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049–2066. doi:10.3748/wjg.15.2049.
  • Dann AT, Kenyon AP, Wierzbicki AS, et al. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2006;107(1):106–114. doi:10.1097/01.AOG.0000189096.94874.9c.
  • Martineau MG, Raker C, Dixon PH, et al. The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care. 2015;38(2):243–248. doi:10.2337/dc14-2143.
  • Goulis DG, Walker IA, de Swiet M, et al. Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases. Hypertens Pregnancy. 2004;23(1):19–27. doi:10.1081/PRG-120028278.
  • Manzotti C, Casazza G, Stimac T, et al. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev. 2019;7: CD012546.
  • Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018; 231:180–187. doi:10.1016/j.ejogrb.2018.10.041.
  • Beuers U, Wolters F, Oude Elferink RPJ. Mechanisms of pruritus in cholestasis: understanding and treating the itch. Nat Rev Gastroenterol Hepatol. 2023;20(1):26–36. doi:10.1038/s41575-022-00687-7.
  • Ozkan S, Ceylan Y, Ozkan OV, et al. Review of a challenging clinical issue: intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2015;21(23):7134–7141. doi:10.3748/wjg.v21.i23.7134.
  • Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467–474. doi:10.1002/hep.20336.
  • Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899–909. doi:10.1016/S0140-6736(18)31877-4.
  • Kawakita T, Parikh LI, Ramsey PS, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2015;213(4):570 e1-8–570.e8. doi:10.1016/j.ajog.2015.06.021.
  • Hershkovitz G, Raz Y, Goldinger I, et al. Severe intrahepatic cholestasis of pregnancy-potential mechanism by which fetuses are protected from the hazardous effect of bile acids. J Clin Med. 2023;12(2):616. doi:10.3390/jcm12020616.
  • Oztas E, Erkenekli K, Ozler S, et al. Can routine laboratory parameters predict adverse pregnancy outcomes in intrahepatic cholestasis of pregnancy? J Perinat Med. 2015;43(6):667–674.
  • Walker KF, Chappell LC, Hague WM, et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev. 2020;7(7):CD000493.
  • Zhan Y, Xu T, Chen T, et al. Intrahepatic cholestasis of pregnancy and fetal cardiac dysfunction: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(8):100952. doi:10.1016/j.ajogmf.2023.100952.
  • Majsterek M, Wierzchowska-Opoka M, Makosz I, et al. Bile acids in intrahepatic cholestasis of pregnancy. Diagnostics. 2022;12(11):1–13. doi:10.3390/diagnostics12112746.
  • Girling J, Knight CL, Chappell L. Intrahepatic cholestasis of pregnancy: green-top guideline no. 43 june 2022. BJOG. 2022; Dec129(13):e95–e114. doi:10.1111/1471-0528.17206.
  • Wikstrom Shemer E, Marschall HU, Ludvigsson JF, et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG. 2013;120(6):717–723. doi:10.1111/1471-0528.12174.
  • Wikstrom Shemer EA, Stephansson O, Thuresson M, et al. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. J Hepatol. 2015;63(2):456–461. doi:10.1016/j.jhep.2015.03.010.
  • Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016;40(2):141–153. doi:10.1016/j.clinre.2015.12.008.
  • Liu W, Chen L, Wang W, et al. A comprehensive review of novel biomarkers in the diagnosis of intrahepatic cholestasis of pregnancy. Biomark Med. 2023;17(10):509–521. doi:10.2217/bmm-2023-0190.
  • Turhan U, Şahin B, Dağ İ. Lysyl oxidase like protein-2 (LOXL-2); a novel marker for prediction of intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2021; 34(14):2363–2368.
  • Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health. 1999;4(1–2):35–37. doi:10.1080/13557859998173.
  • Reyes H, Gonzalez MC, Ribalta J, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med. 1978;88(4):487–493. doi:10.7326/0003-4819-88-4-487.
  • Mikucka-Niczyporuk A, Pierzynski P, Lemancewicz A, et al. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis. Prostaglandins Other Lipid Mediat. 2020;147:106399. doi:10.1016/j.prostaglandins.2019.106399.
  • Benifla JL, Dumont M, Levardon M[, et al. Effects of micronized natural progesterone on the liver during the third trimester of pregnancy. Contracept Fertil Sex. 1997;25(2):165–169.
  • Tsur A, Leonard SA, Kan P, et al. Vaginal progesterone is associated with intrahepatic cholestasis of pregnancy. Am J Perinatol. 2023;40(11):1158–1162. doi:10.1055/a-2081-2573.
  • Zipori Y, Bachar G, Farago N, et al. Vaginal progesterone treatment for the prevention of preterm birth and intrahepatic cholestasis of pregnancy: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2020;253:117–120. doi:10.1016/j.ejogrb.2020.08.043.
  • Kubitz R, Droge C, Stindt J, et al. The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol. 2012;36(6):536–553. doi:10.1016/j.clinre.2012.06.006.
  • Xie S, Wei S, Ma X, et al. Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. Front Pharmacol. 2023;14:1173542. doi:10.3389/fphar.2023.1173542.
  • Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis. 2016;20(1):177–189. doi:10.1016/j.cld.2015.08.010.
  • Wikstrom Shemer E, Marschall HU. Decreased 1,25-dihydroxy vitamin D levels in women with intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand. 2010; 89(11):1420–1423. doi:10.3109/00016349.2010.515665.
  • Jelski W, Wolszczak-Biedrzycka B, Zasimowicz-Majewska E, et al. The activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the sera of patients with autoimmune hepatitis. Clin Lab. 2018;64(4):477–481. doi:10.7754/Clin.Lab.2017.170925.
  • Piechota J, Jelski W, Orywal K, et al. The alcohol dehydrogenase isoenzyme (ADH I) as a marker of intrahepatic cholestasis of pregnancy. Sci Rep. 2022;12(1):11071. doi:10.1038/s41598-022-15532-9.
  • Reyes H, Ribalta J, González-Cerón M. Idiopathic cholestasis of pregnancy in a large kindred. Gut. 1976; 17(9):709–713. doi:10.1136/gut.17.9.709.
  • Holzbach RT, Sivak DA, Braun WE. Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology. 1983; 85(1):175–179. doi:10.1016/S0016-5085(83)80246-7.
  • Palmer DG, Eads J. Intrahepatic cholestasis of pregnancy: a critical review. J Perinat Neonatal Nurs. 2000; 14(1):39–51. doi:10.1097/00005237-200006000-00004.
  • van der Woerd WL, van Mil SWC, Stapelbroek JM, et al. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol. 2010;24(5):541–553. Octdoi:10.1016/j.bpg.2010.07.010.
  • Ziol M, Barbu V, Rosmorduc O, et al. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults. Gastroenterology. 2008;135(1):131–141. doi:10.1053/j.gastro.2008.03.044.
  • Jirsa M, Bronský J, Dvořáková L, et al. ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones. World J Gastroenterol. 2014;20(19):5867–5874. doi:10.3748/wjg.v20.i19.5867.
  • Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics. 2004;14(2):91–102. doi:10.1097/00008571-200402000-00003.
  • Wasmuth HE, Glantz A, Keppeler H, et al. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut. 2007;56(2):265–270. doi:10.1136/gut.2006.092742.
  • Mullenbach R, Linton KJ, Wiltshire S, et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet. 2003;40(5):e70.
  • Eloranta ML, Hakli T, Hiltunen M, et al. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol. 2003;38(6):648–652.
  • Dixon PH, van Mil SW, Chambers J, et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut. 2009;58(4):537–544. doi:10.1136/gut.2008.159541.
  • Sookoian S, Castano G, Burgueno A, et al. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy. J Hepatol. 2008;48(1):125–132. doi:10.1016/j.jhep.2007.08.015.
  • Liu X, Lai H, Xin S, et al. Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study. BMC Pregnancy Childbirth. 2021;21(1):110. doi:10.1186/s12884-021-03595-x.
  • Vitale G, Mattiaccio A, Conti A, et al. Genetics in familial intrahepatic cholestasis: clinical patterns and development of liver and biliary cancers: a review of the literature. Cancers. 2022;14(14):3421. doi:10.3390/cancers14143421.
  • Kosinski P, Kedzia M, Mostowska A, et al. Alpha-1 antitrypsin Z variant (AAT PI*Z) as a risk factor for intrahepatic cholestasis of pregnancy. Front Genet. 2021;12:720465. doi:10.3389/fgene.2021.720465.
  • Dixon PH, Levine AP, Cebola I, et al. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nat Commun. 2022;13(1):4840. doi:10.1038/s41467-022-29931-z.
  • Wiel L, Baakman C, Gilissen D, et al. MetaDome: pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Hum Mutat. 2019;40(8):1030–1038.
  • Dixon PH, Sambrotta M, Chambers J, et al. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy. Sci Rep. 2017;7(1):11823. doi:10.1038/s41598-017-11626-x.
  • Dixon PH, Williamson C. The molecular genetics of intrahepatic cholestasis of pregnancy. Obstet Med. 2008; 1(2):65–71. doi:10.1258/om.2008.080010.
  • Aydin GA, Ozgen G, Gorukmez O. The role of genetic mutations in intrahepatic cholestasis of pregnancy. Taiwan J Obstet Gynecol. 2020; 59(5):706–710. doi:10.1016/j.tjog.2020.07.014.
  • Liu X, Lai H, Zeng X, et al. Whole-exome sequencing reveals ANO8 as a genetic risk factor for intrahepatic cholestasis of pregnancy. BMC Pregnancy Childbirth. 2020;20(1):544. doi:10.1186/s12884-020-03240-z.
  • Van Mil SW, Milona A, Dixon PH, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology. 2007;133(2):507–516. doi:10.1053/j.gastro.2007.05.015.
  • Papacleovoulou G, Abu-Hayyeh S, Nikolopoulou E, et al. Maternal cholestasis during pregnancy programs metabolic disease in offspring. J Clin Invest. 2013;123(7):3172–3181. doi:10.1172/JCI68927.